The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
A meta-analysis involving 540,184 individuals found a non-significant trend suggesting that higher intake and circulating levels of ALA might be associated with a reduced incidence of type 2 diabetes. Specifically, an increase of 0.1% in circulating ALA as a fraction of total fats and a daily intake of 0.5g of ALA were linked to potential reductions in type 2 diabetes risk by of 10% and 7%, respectively. However, these results were not statistically significant. (16)
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.